Montana Med School Clash Revives For-Profit Vs. Nonprofit Flap
Two medical schools vie to open in Montana, highlighting the rapid spread of for-profit schools and their previously tarnished business model.
All Coverage
-
-
Covid Was a Tipping Point for Telehealth. If Some Have Their Way, Virtual Visits Are Here to Stay.
Pressure is mounting on Congress and the Biden administration to make permanent pandemic-inspired rules that fueled telehealth growth. Some fear fraud and ballooning costs.
-
Trying to Avoid Racist Health Care, Black Women Seek Out Black Obstetricians
Besides shared culture and values, a Black physician can offer Black patients a sense of safety, validation and trust. By contrast, the impact of systemic racism can show up starkly in childbirth. Black women are three times as likely to die after giving birth as white women in the United States.
-
With Restrictions Tightening Elsewhere, California Moves to Make Abortion Cheaper
California lawmakers are debating a bill that would eliminate out-of-pocket costs that often prevent people from obtaining abortions, proponents say.
-
In Missouri and Other States, Flawed Data Makes It Hard to Track Vaccine Equity
Racial and ethnic categories for vaccination data vary widely from one state to another, complicating efforts to distribute shots where they are needed most. In Missouri, some red flags in the data surfaced, making health officials question its usefulness.
-
Analysis: Mounting Pressure on China About Covid ‘Lab Leak’ Could Backfire
Where the coronavirus originated remains a mystery and the Chinese are bucking demands to let investigators see more.
-
FDA Weighs Approval of a Lucrative Alzheimer’s Drug, but Benefits Are Iffy
The agency is to decide by June 7 whether to greenlight Biogen’s drug aducanumab, despite a near-unanimous rejection of the product by an FDA advisory committee of outside experts in November. Some scientists at the agency have endorsed the drug, though.
-
KHN’s ‘What the Health?’: The Drug Price Dilemma
Republicans, Democrats and the public at large agree that prices for prescription drugs are too high. But no one seems to know how to fix it. Vanderbilt University drug price researcher Stacie Dusetzina explains the basics of why drugs cost so much and why it’s hard to do something about it. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the prospects for policy changes.
-
Many New Moms Get Kicked Off Medicaid 2 Months After Giving Birth. Illinois Will Change That.
Each year, hundreds of thousands of new mothers lose Medicaid coverage after 60 days when their income exceeds limits. But deadly childbirth complications persist months longer.
-
Newsom Wants to Spend Millions on the Health of Low-Income Mothers and Their Babies
Democratic legislators back measures that would end the “pink tax” on diapers and menstrual products, provide mental health support, and pilot a guaranteed-income program.
-
Expanding Insurance Coverage Is Top Priority for New Medicare-Medicaid Chief
Chiquita Brooks-LaSure, the new head of the Centers for Medicare & Medicaid Services, said the administration will focus on getting more people insured and is interested in finding a way to alleviate the gap keeping low-income families in states that haven’t expanded Medicaid from enrolling in Affordable Care Act health plans.
-
Covid’s Long Shadow: Mourning in America
The ‘Grief Pandemic’ Will Torment Americans for Years
More than 5 million Americans lost a loved one to covid, and the ripple effects could lead to serious illness down the road.
-
Doctors Tell How to Make the Most of Your Telehealth Visits
Public health restrictions put in place during the pandemic are loosening, meaning it’s OK to go back to your doctor’s office. But will virtual visits remain an option?
-
Readers and Tweeters React to Racism, Inequities in Health Care
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Q&A
From Racial Justice to Dirty Air, California’s New AG Plots a Progressive Health Care Agenda
In a candid interview, California’s newly appointed attorney general, Rob Bonta, reflects on his progressive roots and says he will pursue a health care agenda centered on the principle that quality medical care is a right, not a privilege.
-
Little-Known Illnesses Turning Up in Covid Long-Haulers
A significant number of post-covid patients suffer from syndromes that few doctors understand.
-
Behind The Byline: Finding a ‘Superstar’ to Interview
Check out KHN’s video series — Behind The Byline: How the Story Got Made. Come along as journalists and producers offer an insider’s view of health care coverage that does not quit.
-
Mississippi’s Black Communities Turned Around Their Covid Rates. Next Up: Make Strides on Vaccines.
Covid-19 tore through Mississippi’s Black population in the pandemic’s early days, but community efforts slowed the rate. Now health officials and community leaders aim to replicate the success as they dole out vaccines.
-
KHN Journalist Combs for Clues on Covid’s Origins
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Biden Administration Signals It’s in No Rush to Allow Canadian Drug Imports
Federal officials asked a court to dismiss a suit by drugmakers over the policy enacted by the Trump administration that would allow states to bring in cheaper prescription medications from Canada. The filing said the lawsuit was moot because it’s unclear when or if the FDA would approve any state’s importation plan.
